Document is current
Any future updates will be listed below
-
Authors
Kos, Milan https://orcid.org/0000-0003-0400-9216
Pijnappel, Esther N.
Buffart, Laurien M.
Balvers, Britt R.
Kampshoff, Caroline S.
Wilmink, Johanna W.
van Laarhoven, Hanneke W. M.
van Oijen, Martijn G. H.
- License Information
-
More Information
Article History
Received: 16 November 2020
Accepted: 19 April 2021
First Online: 12 June 2021
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: M.G.H. van Oijen has received unrestricted research grants from BMS, Lilly, Merck Serono, Nordic, and Servier, outside the submitted work. H.W.M. van Laarhoven has served as a consultant for BMS, Celgene, Lilly, and Nordic and has received unrestricted research grants from Bayern, BMS, Celgene, Lilly, Merck Serono, MSD, Nordic, Philips, and Roche, outside the submitted work. J.W. Wilmink has served as a consultant for Celgene, Servier, and Shire and has received unrestricted research grants from Amgen, AstraZeneca, Celgene, Halozyme, Merck, Novartis, Pfizer, Roche, and Servier, outside the submitted work. The other authors have nothing to declare.
